Intraductal carcinoma is the precursor of carcinoma ex pleomorphic adenoma and is often associated with dysfunctional p53

Histopathology

Volumn 51, Issue 3, 2007, Pages 362-371

  Ihrler, S ^a   Weiler, C ^a   Hirschmann, A ^a   Sendelhofert, A ^a   Lang, S ^b   Guntinas Lichius, O ^c   Arnold, G ^d   Zietz, C ^e   Harrison, J D ^f  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d Hospital Essen Mitte   (Germany)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^f ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Carcinoma ex pleomorphic adenoma; Intraductal carcinoma; p53; Salivary gland carcinoma

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CARCINOMA EX PLEOMORPHIC ADENOMA; CELL PROLIFERATION; CELL STRUCTURE; CELL TRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LASER MICRODISSECTION; MALE; MALIGNANT TRANSFORMATION; MUTATIONAL ANALYSIS; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ADENOMA, PLEOMORPHIC; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-14; KERATIN-7; KI-67 ANTIGEN; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MUTATION; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS, MINOR; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34548131248     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02736.x     Document Type: Article

References (35)

1. Gnepp DR, Brandwein-Gensler MS, El-Naggar AK, Nagao T. Carcinoma ex pleomorphic adenoma. In Barnes L, Eveson JW, Reichart P, Sidransky D eds. World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. Lyon : IARC Press 2005 242 243.
2. Auclair PL, Ellis GL. Atypical features in salivary gland mixed tumors: their relationship to malignant transformation. Mod. Pathol. 1996 9 652 657.
3. Di Palma S, Skálová A, Vanìèek T, Simpson RHW, Stárek I, Leivo I. Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry. Histopathology 2005 46 144 152.
4. Félix A, Rosa-Santos J, Mendonça ME, Torrinha F, Soares J. Intracapsular carcinoma ex pleomorphic adenoma. Report of a case with unusual metastatic behaviour. Oral Oncol. 2002 38 107 110.
5. Félix A, Rosa JC, Fonseca I, Cidadão A, Soares J. Pleomorphic adenoma and carcinoma ex pleomorphic adenoma: immunohistochemical demonstration of the association between tenascin expression and malignancy. Histopathology 2004 45 187 192.
6. LiVolsi VA, Perzin KH. Malignant mixed tumors arising in salivary glands. I. Carcinomas arising in benign mixed tumors: a clinicopathologic study. Cancer 1977 39 2209 2230.
7. Lewis JE, Olsen KD, Sebo TJ. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum. Pathol. 2001 32 596 604.
8. Altemani A, Martins MT, Freitas L, Soares F, Araújo NS, Araújo VC. Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression. Histopathology 2005 46 635 641.
9. Li X, Tsuji T, Wen S, Mimura Y, Sasaki K, Shinozaki F. Detection of numeric abnormalities of chromosome 17 and p53 deletions by fluorescence in situ hybridization in pleomorphic adenomas and carcinomas in pleomorphic adenoma. Correlation with p53 expression. Cancer 1997 79 2314 2319.
10. Nordkvist A, Roijer E, Bang G et al. Expression and mutation patterns of p53 in benign and malignant salivary gland tumors. Int. J. Oncol. 2000 16 477 483.
11. Righi PD, Li YQ, Deutsch M et al. The role of the p53 gene in the malignant transformation of pleomorphic adenomas of the parotid gland. Anticancer Res. 1994 14 2253 2257.
12. Yamamoto Y, Kishimoto Y, Wistuba II et al. DNA analysis at p53 locus in carcinomas arising from pleomorphic adenomas of salivary glands: comparison of molecular study and p53 immunostaining. Pathol. Int. 1998 48 265 272.
13. Rosa JC, Fonseca I, Félix A, Soares J. p53 immunoexpression in carcinomas arising in pleomorphic adenoma. Int. J. Surg. Pathol. 1996 3 257 262.
14. Ihrler S, Blasenbreu-Vogt S, Sendelhofert A, Lang S, Zietz C, Löhrs U. Differential diagnosis of salivary acinic cell carcinoma and adenocarcinoma (NOS). A comparison of (immuno-)histochemical markers. Pathol. Res. Pract. 2002 198 777 783.
15. Ihrler S, Zietz C, Sendelhofert A, Lang S, Blasenbreu-Vogt S, Löhrs U. A morphogenetic concept of salivary duct regeneration and metaplasia. Virchows Arch. 2002 440 519 526.
16. Ihrler S, Blasenbreu-Vogt S, Sendelhofert A, Rossle M, Harrison JD, Löhrs U. Regeneration in chronic sialadenitis: an analysis of proliferation and apoptosis based on double immunohistochemical labelling. Virchows Arch. 2004 444 356 361.
17. Ihrler S, Sendelhofert A, Weiler C, Hagedorn H, Harrison JD. Preinvasive intraductal neoplasia in salivary adenocarcinoma, not otherwise specified. Virchows Arch. 2006 449 159 163.
18. Klöppel G, Hruban RH, Longnecker DS, Adler G, Kern SE, Partanen TJ. Ductal adenocarcinoma of the pancreas. In Hamilton SR, Aaltonen LA eds. World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon : IARC Press 2000 221 228.
19. Tavassoli FA, Höfler H, Rosai J. Intraductal proliferative lesions. In Tavassoli FA, Devilee P eds. World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon : IARC Press 2003 63 73.
20. Zietz C, Rossle M, Haas C et al. MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas. Am. J. Pathol. 1998 153 1425 1433.
21. Diebold J, Seemuller F, Lohrs U. K-RAS mutations in ovarian and extraovarian lesions of serous tumors of borderline malignancy. Lab. Invest. 2003 83 251 258.
22. Gjerdrum LM, Lielpetere I, Rasmussen LM, Bendix K, Hamilton-Dutoit S. Laser-assisted microdissection of membrane-mounted paraffin sections for polymerase chain reaction analysis: identification of cell populations using immunohistochemistry and in situ hybridization. J. Mol. Diagn. 2001 3 105 110.
23. Aigner T, Neureiter D, Völker U, Belke J, Kirchner T. Epithelial-mesenchymal transdifferentiation and extracellular matrix gene expression in pleomorphic adenomas of the parotid salivary gland. J. Pathol. 1998 186 178 185.
24. Debiec-Rychter M, van Valckenborgh I, van den Broeck C et al. Histologic localization of PLAG1 (pleomorphic adenoma gene 1) in pleomorphic adenoma of the salivary gland: cytogenetic evidence of common origin of phenotypically diverse cells. Lab. Invest. 2001 81 1289 1297.
25. Harrison JD, Auger DW. Ultrastructural cytochemistry of phosphatases in the ductal component of pleomorphic adenoma of human parotid and submandibular salivary glands. Histochem. J. 1982 14 703 711.
26. Harrison JD, Auger DW. Ultrastructural observations on luminal structures of pleomorphic adenoma of parotid and submandibular salivary glands of man. Virchows Arch. A Pathol. Anat. Histopathol. 1989 415 559 563.
27. Harrison JD, Auger DW. Ultrastructural morphology of secretory granules in pleomorphic adenoma of human parotid and submandibular salivary glands. Arch. Oral Biol. 1989 34 759 761.
28. Harrison JD, Auger DW. Mucosubstance histochemistry of pleomorphic adenoma of parotid and submandibular salivary glands of man: light and electron microscopy. Histochem. J. 1991 23 293 302.
29. El-Naggar AK, Callender D, Coombes MM, Hurr K, Luna MA, Batsakis JG. Molecular genetic alterations in carcinoma ex-pleomorphic adenoma: a putative progression model? Genes Chromosomes Cancer 2000 27 162 168.
30. Hall PA, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry? - Revisited! J. Pathol. 1994 172 1 4.
31. Gasco M, Crook T. The p53 network in head and neck cancer. Oral Oncol. 2003 39 222 231.
32. Martins C, Fonseca I, Roque L et al. PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: a combined study using chromosome banding, in situ hybridization and immunocytochemistry. Mod. Pathol. 2005 18 1048 55.
33. Stennert E, Wittekindt C, Klussmann JP, Arnold G, Guntinas-Lichius O. Recurrent pleomorphic adenoma of the parotid gland: a prospective histopathological and immunohistochemical study. Laryngoscope 2004 114 158 163.
34. de Araújo VC, Loducca SVL, Sobral APV, Kowalski LP, Soares F, de Araújo NS. Salivary duct carcinoma: cytokeratin 14 as a marker of in-situ intraductal growth. Histopathology 2002 41 244 249.
35. Brandwein-Gensler M, Hille J, Wang BY et al. Low-grade salivary duct carcinoma: description of 16 cases. Am. J. Surg. Pathol. 2004 28 1040 1044.